Status:
UNKNOWN
Structural and Functional Characterization of Rare Ocular Diseases
Lead Sponsor:
Barcelona Macula Foundation
Conditions:
Retinitis Pigmentosa
Stargardt Disease 1
Eligibility:
All Genders
18+ years
Brief Summary
Rare ocular diseases (ROD) are a heterogeneous group of ocular diseases that affect very few people and, generally, for which no tretament is available. An important subgroup of these diseases are inh...
Eligibility Criteria
Inclusion
- Male or female 18 years or older with a diagnosis of a ROD affecting the posterior segment
- Patients able to undergo all required ophthalmic exams
- Patients able and willing to sign an informed consent
Exclusion
- Patients with other concomitant posterior segment disorders
- Patients taking drugs known to affect the retina and/or optic nerve
- Patients that underwent an intraocular surgery (aside from phacoemulsification with intraocular lens implantation), corneal or glaucoma surgery
- Patients who have participated in the past 12 months or that are currently participating in clinical trials for an ocular disease
Key Trial Info
Start Date :
November 24 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 24 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05258032
Start Date
November 24 2021
End Date
November 24 2025
Last Update
March 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de la màcula
Barcelona, Spain, 08022